• Je něco špatně v tomto záznamu ?

microRNAs in Cerebrovascular Disease

O. Volný, L. Kašičková, D. Coufalová, P. Cimflová, J. Novák,

. 2015 ; 888 (-) : 155-95.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020095

Cardiovascular diseases are major causes of morbidity and mortality in developed countries. Cerebrovascular diseases, especially stroke, represent major burden of disability and economy impact. Major advances in primary and secondary prevention and therapy are needed in order to tackle this public health problem. Our better understanding of pathophysiology is essential in order to develop novel diagnostic and therapeutic tools and strategies. microRNAs are a family of important post-transcriptional regulators of gene expression and their involvement in the pathophysiology of cerebrovascular diseases has already been reported. Moreover, microRNAs may represent above-mentioned potential diagnostic and therapeutic tools in clinical practice. Within this chapter, we briefly describe basic epidemiology, aetiology and clinical manifestation of following cerebrovascular diseases: extracranial carotid atherosclerosis, acute stroke, intracranial aneurysms and cerebral arterio-venous malformations. Further, in each chapter, the current knowledge about the involvement of specific microRNAs and their potential use in clinical practice will be summarized. More specifically, within the subchapter "miRNAs in carotid atherosclerosis", general information about miRNA involvement in atherosclerosis will be described (miR-126, miR-17-92, miR-155 and others) with special emphasis put on miRNAs affecting carotid plaque progression and stability (e.g. miR-145, miR-146 or miR-217). In the subchapter "miRNAs in acute stroke", we will provide insight into recent knowledge from animal and human studies concerning miRNA profiling in acute stroke and their expression dynamics in brain tissue and extracellular fluids (roles of, e.g. let-7 family, miR-21, miR-29 family, miR-124, miR-145, miR-181 family, miR-210 and miR-223). Subchapters dealing with "miRNAs and AV malformations" and "miRNAs and intracranial aneurysms" will focus on miR-21, miR-26, miR-29 family and miR-143/145.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020095
003      
CZ-PrNML
005      
20160725111129.0
007      
ta
008      
160722s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/978-3-319-22671-2_9 $2 doi
024    7_
$a 10.1007/978-3-319-22671-2_9 $2 doi
035    __
$a (PubMed)26663183
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Volný, Ondřej $u Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Pekarska 53, Brno, 656 91, Czech Republic. 214565@mail.muni.cz. Department of Anatomy, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. 214565@mail.muni.cz. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, Brno, 656 91, Czech Republic. 214565@mail.muni.cz.
245    10
$a microRNAs in Cerebrovascular Disease / $c O. Volný, L. Kašičková, D. Coufalová, P. Cimflová, J. Novák,
520    9_
$a Cardiovascular diseases are major causes of morbidity and mortality in developed countries. Cerebrovascular diseases, especially stroke, represent major burden of disability and economy impact. Major advances in primary and secondary prevention and therapy are needed in order to tackle this public health problem. Our better understanding of pathophysiology is essential in order to develop novel diagnostic and therapeutic tools and strategies. microRNAs are a family of important post-transcriptional regulators of gene expression and their involvement in the pathophysiology of cerebrovascular diseases has already been reported. Moreover, microRNAs may represent above-mentioned potential diagnostic and therapeutic tools in clinical practice. Within this chapter, we briefly describe basic epidemiology, aetiology and clinical manifestation of following cerebrovascular diseases: extracranial carotid atherosclerosis, acute stroke, intracranial aneurysms and cerebral arterio-venous malformations. Further, in each chapter, the current knowledge about the involvement of specific microRNAs and their potential use in clinical practice will be summarized. More specifically, within the subchapter "miRNAs in carotid atherosclerosis", general information about miRNA involvement in atherosclerosis will be described (miR-126, miR-17-92, miR-155 and others) with special emphasis put on miRNAs affecting carotid plaque progression and stability (e.g. miR-145, miR-146 or miR-217). In the subchapter "miRNAs in acute stroke", we will provide insight into recent knowledge from animal and human studies concerning miRNA profiling in acute stroke and their expression dynamics in brain tissue and extracellular fluids (roles of, e.g. let-7 family, miR-21, miR-29 family, miR-124, miR-145, miR-181 family, miR-210 and miR-223). Subchapters dealing with "miRNAs and AV malformations" and "miRNAs and intracranial aneurysms" will focus on miR-21, miR-26, miR-29 family and miR-143/145.
650    _2
$a zvířata $7 D000818
650    _2
$a mozek $x metabolismus $x patologie $7 D001921
650    _2
$a ischemie mozku $x komplikace $7 D002545
650    _2
$a nemoci arterie carotis $x diagnóza $x genetika $x terapie $7 D002340
650    _2
$a cerebrovaskulární poruchy $x diagnóza $x genetika $x terapie $7 D002561
650    _2
$a modely nemocí na zvířatech $7 D004195
650    12
$a regulace genové exprese $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a cévní mozková příhoda $x etiologie $x genetika $x terapie $7 D020521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kašičková, Linda $u Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Pekarska 53, Brno, 656 91, Czech Republic. 381169@mail.muni.cz. Department of Anatomy, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. 381169@mail.muni.cz.
700    1_
$a Coufalová, Dominika $u Department of Anatomy, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. 381169@mail.muni.cz. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, Brno, 656 91, Czech Republic. 381169@mail.muni.cz.
700    1_
$a Cimflová, Petra $u Department of Radiology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Pekarska 53, Brno, 656 91, Czech Republic. petra.cimflova@fnusa.cz.
700    1_
$a Novák, Jan $u 2nd Department of Internal Medicine, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Pekarska 53, Brno, 656 91, Czech Republic. jnmedved@seznam.cz. Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, 62500, Czech Republic. jnmedved@seznam.cz. Department of Physiology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic. jnmedved@seznam.cz.
773    0_
$w MED00008501 $t Advances in experimental medicine and biology $x 0065-2598 $g Roč. 888, č. - (2015), s. 155-95
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26663183 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160725111347 $b ABA008
999    __
$a ok $b bmc $g 1154765 $s 944623
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 888 $c - $d 155-95 $i 0065-2598 $m Advances in experimental medicine and biology $n Adv Exp Med Biol $x MED00008501
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Možnosti archivace